Artificial intelligence-driven clinical decision support systems for early detection and precision therapy in oral cancer: a mini review.

Front Oral Health

Department of Clinical Sciences, College of Dentistry, Centre of Medical and Bio-Allied Health Sciences and Research, Ajman University, Ajman, United Arab Emirates.

Published: April 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Oral cancer (OC) is a significant global health burden, with life-saving improvements in survival and outcomes being dependent on early diagnosis and precise treatment planning. However, diagnosis and treatment planning are predicated on the synthesis of complicated information derived from clinical assessment, imaging, histopathology and patient histories. Artificial intelligence-based clinical decision support systems (AI-CDSS) provides a viable solution that can be implemented via advanced methodologies for data analysis, and synthesis for better diagnostic and prognostic evaluation. This review presents AI-CDSS as a promising solution through advanced methodologies for comprehensive data analysis. In addition, it examines current implementations of AI-CDSS that facilitate early OC detection, precise staging, and personalized treatment planning by processing multimodal patient information through machine learning, computer vision, and natural language processing. These systems effectively interpret clinical results, identify critical disease patterns (including clinical stage, site, tumor dimensions, histopathologic grading, and molecular profiles), and construct comprehensive patient profiles. This comprehensive AI-CDSS approach allows for early cancer detection, a reduction in diagnostic delays and improved intervention outcomes. Moreover, the AI-CDSS also optimizes treatment plans on the basis of unique patient parameters, tumor stages and risk factors, providing personalized therapy.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12066789PMC
http://dx.doi.org/10.3389/froh.2025.1592428DOI Listing

Publication Analysis

Top Keywords

treatment planning
12
clinical decision
8
decision support
8
support systems
8
early detection
8
oral cancer
8
advanced methodologies
8
data analysis
8
clinical
5
ai-cdss
5

Similar Publications

Background: To assess the efficacy and safety of tenecteplase in patients presenting within 24 hours of symptom onset with a large vessel occlusion and target mismatch on perfusion computed tomography.

Methods: ETERNAL-LVO was a prospective, randomized, open-label, blinded end point, phase 3, superiority trial where adult participants with a large vessel occlusion, presenting within 24 hours of onset with salvageable tissue on computed tomography perfusion, were randomized to tenecteplase 0.25 mg/kg or standard care across 11 primary and comprehensive stroke centers in Australia.

View Article and Find Full Text PDF

Background: Perforation of artery causing bleeding is a rare but serious complication of percutaneous coronary intervention (PCI), with potentially life-threatening consequences. Prompt recognition and management are crucial, particularly in high-risk patients or complex procedures. Coils are essential tools for sealing perforated or ruptured vessels, preventing further haemorrhage and stabilising the patient.

View Article and Find Full Text PDF

Digital twins in nuclear medicine: A proposition of a modular pipeline for dosimetry protocol optimization in molecular radiotherapy.

Comput Struct Biotechnol J

August 2025

Institut de Recherche en Cancérologie de Montpellier (IRCM), Équipe Labellisée Ligue Contre le Cancer, INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier (ICM), Montpellier, France.

Digital twins (DTs) are emerging tools for simulating and optimizing therapeutic protocols in personalized nuclear medicine. In this paper, we present a modular pipeline for constructing patient-specific DTs aimed at assessing and improving dosimetry protocols in PRRT such as therapy. The pipeline integrates three components: (i) an anatomical DT, generated by registering patient CT scans with an anthropomorphic model; (ii) a functional DT, based on a physiologically-based pharmacokinetic (PBPK) model created in SimBiology; and (iii) a virtual clinical trial module using GATE to simulate particle transport, image simulation, and absorbed dose distribution.

View Article and Find Full Text PDF

COVID-19 and the moral failure to protect the most vulnerable.

J Healthc Sci Humanit

January 2024

Director, Northern Plains Ethics Institute, Editor, Springer's International Library of Bioethics, Professor of Philosophy and Ethics, History, Philosophy, and Religious Studies-Dept. 2340, Minard Hall 422J, P.O Box 6050, North Dakota State University, Fargo, ND 58108, [701] 231-7038, Email: dennis.

The USA's COVID-19 pandemic experience is an example of privileged thinking that what generally works for those in power ought to be the standard for what makes medical interventions, research, treatments, and policy ethical. As a result of not focusing on doing whatever was required for vulnerable or susceptible populations or their members to achieve their health and flourishing, there are a disproportionate numbers of COVID-19 infections and deaths in Black, Hispanic, and indigenous communities. Future studies will likely show even more harm and larger health failure than known of now.

View Article and Find Full Text PDF

The study investigates the potential impact of COVID-19 vaccines on menstrual cycles, with a particular focus on Black women and those with underlying reproductive health conditions. Despite numerous reports of menstrual irregularities post-vaccination, research on this subject remains limited. The study aims to explore whether these irregular cycles could indicate broader reproductive health concerns, such as reduced ovarian reserve, and whether certain vaccines are more likely to cause these changes.

View Article and Find Full Text PDF